Nebilox (Nebivolol)

Nebivolol, the active ingredient in Nebilox, is a beta blocker presented as an oral formulation for oral use. It selectively blocks β1‑adrenergic receptors and provides nitric‑oxide‑mediated vasodilation, helping to lower blood pressure and improve cardiac output in adult patients with hypertension or heart failure.

GNH USA supplies Nebilox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory adherence, and reliable logistics across global markets.

Nebivolol is used in the cardiovascular therapeutic area to manage blood pressure and cardiac function.

- Hypertension: lowers systolic and diastolic blood pressure, reducing vascular resistance. - Heart failure with reduced ejection fraction (HFrEF): improves left ventricular ejection fraction and decreases hospitalization risk. - Left ventricular systolic dysfunction: enhances cardiac output and overall heart performance.

Common side effects are generally mild and may resolve with continued therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness: often related to blood pressure reduction. - Fatigue: feeling of reduced energy. - Nasal congestion: mild blockage of nasal passages. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Severe bradycardia: markedly slow heart rate requiring medical attention. - Symptomatic hypotension: significant drop in blood pressure causing faintness. - AV block: impaired electrical conduction in the heart. - Bronchospasm: breathing difficulty, especially in asthmatic patients. - Allergic reactions: rash, itching, or swelling indicating hypersensitivity.

Before initiating Nebivolol, consider the following safety measures.

- Monitor blood pressure: check regularly to ensure therapeutic levels. - Assess heart rate: watch for bradycardia, especially in patients with pre‑existing low heart rates. - Use caution in asthma or COPD: β‑blockade may exacerbate bronchospasm. - Avoid abrupt discontinuation: sudden stop can cause rebound hypertension. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Nebivolol may interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Verapamil or diltiazem: risk of severe bradycardia and AV block. - Other beta blockers: additive cardiac depression and excessive heart rate reduction. - Clonidine: abrupt withdrawal may precipitate rebound hypertension.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolytes and blood pressure for additive effects. - NSAIDs: may attenuate the antihypertensive response of nebivolol.